Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatraman Radhakrishnan

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 28, 2017
Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer CentreSourav Mishra, Venkatraman Radhakrishnan, Prasanth Ganesan, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 24, 2018
Prognostic Utility of the IPS 3 Score for Predicting Outcomes in Advanced Hodgkin LymphomaPrasanth Ganesan, Manikandan Dhanushkodi, Trivadi S Ganesan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2018
Experience with the Use of Nilotinib in Indian PatientsAvaronnan Manuprasad, Prasanth Ganesan, Trivadi S Ganesan, et al.
Medical Oncology (Northwood, London, England)|February 7, 2019
Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countriesS V Saju, Venkatraman Radhakrishnan, Trivadi S Ganesan, et al.
Hematology, Transfusion and Cell Therapy|February 2, 2021
Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care centerKarthik Bommannan, Jhansi Rani Arumugam, Venkatraman Radhakrishnan, et al.
Leukemia & Lymphoma|June 12, 2019
CD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy eraB K Karthik Bommannan, Jhansi Rani Arumugam, Shirley Sundersingh, et al.
Cancer|February 24, 2022
A proposed global framework for pediatric cancer communication researchDylan E Graetz, Ana Caceres-Serrano, Venkatraman Radhakrishnan, et al.
South Asian Journal of Cancer|June 26, 2024
Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma-Experience from an Indian CenterMuthiah Vaikundaraja Indhuja, Sivasree Kesana, Nikita Mehra, et al.
Clinical Neuroradiology|March 16, 2010
T1 hyperintense cystic lesion - an epidermoid or an abscess?Somenath Chatterjee, Kythasandra Shivakumar Deepak, Shivanna Banuprakash, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomitingBernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 28, 2017
Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer CentreSourav Mishra, Venkatraman Radhakrishnan, Prasanth Ganesan, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 24, 2018
Prognostic Utility of the IPS 3 Score for Predicting Outcomes in Advanced Hodgkin LymphomaPrasanth Ganesan, Manikandan Dhanushkodi, Trivadi S Ganesan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2018
Experience with the Use of Nilotinib in Indian PatientsAvaronnan Manuprasad, Prasanth Ganesan, Trivadi S Ganesan, et al.
Medical Oncology (Northwood, London, England)|February 7, 2019
Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countriesS V Saju, Venkatraman Radhakrishnan, Trivadi S Ganesan, et al.
Hematology, Transfusion and Cell Therapy|February 2, 2021
Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care centerKarthik Bommannan, Jhansi Rani Arumugam, Venkatraman Radhakrishnan, et al.
Leukemia & Lymphoma|June 12, 2019
CD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy eraB K Karthik Bommannan, Jhansi Rani Arumugam, Shirley Sundersingh, et al.
Cancer|February 24, 2022
A proposed global framework for pediatric cancer communication researchDylan E Graetz, Ana Caceres-Serrano, Venkatraman Radhakrishnan, et al.
South Asian Journal of Cancer|June 26, 2024
Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma-Experience from an Indian CenterMuthiah Vaikundaraja Indhuja, Sivasree Kesana, Nikita Mehra, et al.
Clinical Neuroradiology|March 16, 2010
T1 hyperintense cystic lesion - an epidermoid or an abscess?Somenath Chatterjee, Kythasandra Shivakumar Deepak, Shivanna Banuprakash, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomitingBernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, et al.
Pageof 15